Vitamin D and obesity

Simon Vanlint, Simon Vanlint

Abstract

Obesity is a significant health problem world-wide, particularly in developed nations. Vitamin D deficiency is pandemic, and has been implicated in a wide variety of disease states. This paper seeks to examine the consistently reported relationship between obesity and low vitamin D concentrations, with reference to the possible underlying mechanisms. The possibility that vitamin D may assist in preventing or treating obesity is also examined, and recommendations for future research are made. There is a clear need for adequately-powered, prospective interventions which include baseline measurement of 25D concentrations and involve adequate doses of supplemental vitamin D. Until such studies have been reported, the role of vitamin D supplementation in obesity prevention remains uncertain.

References

    1. Noncommunicable Diseases Country Profiles. World Health Organisation; Geneva, Switzerland: 2011. p. 209.
    1. Pi-Sunyer F.X. The obesity epidemic: Pathophysiology and consequences of obesity. Obes. Res. 2002;10:97S–104S. doi: 10.1038/oby.2002.202.
    1. Goodpaster B., Krishnaswami S., Harris T., Katsiaras A., Kritchevsky S., Simonsick E., Nevitt M., Holvoet P., Newman A. Obesity, regional body fat distribution, and the metabolic syndrome in older men and women. Arch. Int. Med. 2005;165:777–783. doi: 10.1001/archinte.165.7.777.
    1. Stranges S., Trevisan M., Dorn J., Dmochowski J., Donahue R. Body fat distribution, liver enzymes, and risk of hypertension: Evidence from the western New York study. Hypertension. 2005;46:1186–1193. doi: 10.1161/01.HYP.0000185688.81320.4d.
    1. Lementowski P., Zelicof S. Obesity and osteoarthritis. Am. J. Orthop. 2008;37:148–151.
    1. Must A., Spadano J., Coakley E., Field A., Colditz G., Dietz W. The disease burden associated with overweight and obesity. JAMA. 1999;282:1523–1529. doi: 10.1001/jama.282.16.1523.
    1. Bell N.H., Epstein S., Greene A., Shary J., Oexmann M.J., Shaw S. Evidence for alteration of the vitamin D-endocrine system in obese subjects. J. Clin. Invest. 1985;76:370–373. doi: 10.1172/JCI111971.
    1. Liel Y., Ulmer E., Shary J., Hollis B., Bell N. Low circulating vitamin D in obesity. Calcif. Tissue Int. 1988;43:199–201.
    1. Parikh S.J., Edelman M., Uwaifo G.I., Freedman R.J., Semega-Janneh M., Reynolds J., Yanovski J.A. The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J. Clin. Endocrinol. Metab. 2004;89:1196–1199. doi: 10.1210/jc.2003-031398.
    1. Lagunova Z., Porojnicu A., Lindberg F., Hexeberg S., Moan J. The dependency of vitamin D status on body mass index, gender, age and season. Anticancer Res. 2009;29:3713–3720.
    1. Arunabh S., Pollack S., Yeh J., Aloia J.F. Body fat content and 25-hydroxyvitamin D levels in healthy women. J. Clin. Endocrinol. Metab. 2003;88:157–161. doi: 10.1210/jc.2002-020978.
    1. Vimeswaran K., Berry D., Lu C., Pilz S., Hiraki L., Cooper J., Dastani Z., Li R., Houston D., Wood A. Causal relationship between obesity and vitamin D status: Bi-directional mendelian randomization analysis of multiple cohorts. PLoS Med. 2013;10:1549–1676.
    1. Kamycheva E., Sundsfjord J., Jorde R. Serum parathyroid hormone level is associated with body mass index. The 5th tromso study. Eur. J. Endocrinol. 2004;151:167–172. doi: 10.1530/eje.0.1510167.
    1. Kamycheva E., Joakimsen R.M., Jorde R. Intakes of calcium and vitamin D predict body mass index in the population of northern norway. J. Nutr. 2003;133:102–106.
    1. Kull M., Kallikorm R., Lember M. Body mass index determines sunbathing habits: Implications on vitamin D levels. Intern. Med. J. 2009;39:256–258. doi: 10.1111/j.1445-5994.2009.01900.x.
    1. Harris S.S., Dawson-Hughes B. Reduced sun exposure does not explain the inverse association of 25-hydroxyvitamin D with percent body fat in older adults. J. Clin. Endocrinol. Metab. 2007;92:3155–3157. doi: 10.1210/jc.2007-0722.
    1. Holick M.F., Matsuoka L.Y., Wortsman J. Age, vitamin D and solar ultraviolet. Lancet. 1989;334:1104–1105.
    1. Verbraecken J., van de Heyning P., De Backer W., van Gaal L. Body surface area in normal-weight, overweight, and obese adults. A comparison study. A comparison study. Metabolism. 2006;55:515–524.
    1. Wortsman J., Matsuoka L.Y., Chen T.C., Lu Z., Holick M.F. Decreased bioavailability of vitamin D in obesity. Am. J. Clin. Nutr. 2000;72:690–693.
    1. Florez H., Martinez R., Chacra W., Strickman-Stein N., Levis S. Outdoor exercise reduces the risk of hypovitaminosis D in the obese. J. Steroid Biochem. Mol. Biol. 2007;103:679–681. doi: 10.1016/j.jsbmb.2006.12.032.
    1. Hewitt S., Søvik T., Aasheim E., Kristinsson J., Jahnsen J., Birketvedt G., Bøhmer T., Eriksen E., Mala T. Secondary hyperparathyroidism, vitamin D sufficiency, and serum calcium 5years after gastric bypass and duodenal switch. Obes. Surg. 2013;23:384–390. doi: 10.1007/s11695-012-0772-3.
    1. Aarts E., van Groningen L., Horst R., Telting D., van Sorge A., Janssen I., de Boer H. Vitamin D absorption: Consequences of gastric bypass surgery. Eur. J. Endocrinol. 2011;164:827–832. doi: 10.1530/EJE-10-1126.
    1. Shapses S.A., Sukumar D., Schneider S.H., Schlussel Y., Brolin R.E., Taich L. Hormonal and dietary influences on true fractional calcium absorption in women: Role of obesity. Osteoporosis Int. 2012;23:2607–2614. doi: 10.1007/s00198-012-1901-5.
    1. Bell N.H., Shaw S., Turner R.T. Evidence that 1,25-dihydroxyvitamin D3 inhibits the hepatic production of 25-hydroxyvitamin D in man. J. Clin. Invest. 1984;74:1540–1544. doi: 10.1172/JCI111568.
    1. Wamberg L., Christiansen T., Paulsen S.K., Fisker S., Rask P., Rejnmark L., Richelsen B., Pedersen S.B. Expression of vitamin D-metabolizing enzymes in human adipose tissue—the effect of obesity and diet-induced weight loss. Int. J. Obes. 2012 doi: 10.1038/ijo.2012.112.
    1. Kong J., Li Y.C. Molecular mechanism of 1,25-dihydroxyvitamin D3 inhibition of adipogenesis in 3t3-l1 cells. Am. J. Physiol. Endocrinol. Metab. 2006;290:E916–E924. doi: 10.1152/ajpendo.00410.2005.
    1. Sergeev I. 1,25-dihydroxyvitamin D3 induces Ca2+-mediated apoptosis in adipocytes via activation of calpain and caspase-12. Biochem. Biophys. Res. Commun. 2009;384:18–21. doi: 10.1016/j.bbrc.2009.04.078.
    1. Rosenstreich S., Rich C., Volwiler W. Deposition in and release of vitamin D3 from body fat: Evidence for a storage site in the rat. J. Clin. Invest. 1971;50:679–687. doi: 10.1172/JCI106538.
    1. Blum M., Dolnikowski G., Seyoum E., Harris S., Booth S., Peterson J., Saltzman E., Dawson-Hughes B. Vitamin D3 in fat tissue. Endocrine. 2008;33:90–94. doi: 10.1007/s12020-008-9051-4.
    1. Drincic A.T., Armas L.A.G., van Diest E.E., Heaney R.P. Volumetric dilution, rather than sequestration best explains the low vitamin D status of obesity. Obesity. 2012;20:1444–1448. doi: 10.1038/oby.2011.404.
    1. Ding C., Gao D., Wilding J., Trayhurn P., Bing C. Vitamin D signalling in adipose tissue. Br. J. Nutr. 2012;108:1915–1923. doi: 10.1017/S0007114512003285.
    1. Song Q., Sergeev I.N. Calcium and vitamin D in obesity. Nutr. Res. Rev. 2012;25:130–141. doi: 10.1017/S0954422412000029.
    1. Wamberg L., Cullberg Y., Rejnmark L., Richelsen B., Pedersen S. Investigations of the anti-inflammatory effects of vitamin D in adipose tissue: Results from an in vitro study and a randomized controlled trial. Horm. Metab. Res. 2013 in press.
    1. Mai X.-M., Chen Y., Camargo C.A., Langhammer A. Cross-sectional and prospective cohort study of serum 25-hydroxyvitamin D level and obesity in adults: The hunt study. Am. J. Epidemiol. 2012;175:1029–1036. doi: 10.1093/aje/kwr456.
    1. Zhu W., Cai D., Wang Y., Ning L., Hu Q., Qi Y., Ma S., Amarasekara S. Calcium plus vitamin D3 supplementation facilitated fat loss in overweight and obese college students with very-low calcium consumption: A randomized controlled trial. Nutr. J. 2013;12:8–12. doi: 10.1186/1475-2891-12-8.
    1. Rosenblum J.L., Castro V.M., Moore C.E., Kaplan L.M. Calcium and vitamin D supplementation is associated with decreased abdominal visceral adipose tissue in overweight and obese adults. Am. J. Clin. Nutr. 2012;95:101–108. doi: 10.3945/ajcn.111.019489.
    1. Zhou J., Zhou L.-J., Watson P., Zhang Q., Lappe J. The effect of calcium and vitamin D supplementation on obesity in postmenopausal women: Secondary analysis for a large-scale, placebo controlled, double-blind, 4-year longitudinal clinical trial. Nutr. Metab. 2010;7:62. doi: 10.1186/1743-7075-7-62.
    1. Salehpour A., Hosseinpanah F., Shidfar F., Vafa M., Razaghi M., Dehghani S., Hoshiarrad A., Gohari M. A 12-week double-blind randomized clinical trial of vitamin D3 supplementation on body fat mass in healthy overweight and obese women. Nutr. J. 2012;11:78. doi: 10.1186/1475-2891-11-78.
    1. Sneve M., Figenschau Y., Jorde R. Supplementation with cholecalciferol does not result in weight reduction in overweight and obese subjects. Eur. J. Endocrinol. 2008;159:675–684. doi: 10.1530/EJE-08-0339.
    1. Rock C.L., Emond J.A., Flatt S.W., Heath D.D., Karanja N., Pakiz B., Sherwood N.E., Thomson C.A. Weight loss is associated with increased serum 25-hydroxyvitamin D in overweight or obese women. Obesity. 2012;20:2296–2301. doi: 10.1038/oby.2012.57.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다